Meeting
2018 Genitourinary Cancers Symposium
Patients perspectives on adjuvant therapy in renal cell carcinoma.
Authors
Dena Battle
KCCure, Alexandria, VA
Dena Battle , Eric Jonasch , Hans J. Hammers , Ithaar Derweesh , Daniel J. George , Axel Bex , Borje Ljungberg , Michael D. Staehler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 644)
DOI
10.1200/JCO.2018.36.6_suppl.644
Abstract #
644
Poster Bd #
H15
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Outcomes of systemic therapy in relapsed renal cell carcinoma (RCC) treated with adjuvant sunitinib (AS).
First Author: Guillermo de Velasco
Poster
2018 ASCO Annual Meeting
Anxiety and patients: Perspectives on surveillance and adjuvant therapy in renal cell carcinoma.
First Author: Dena Battle
Poster
2023 ASCO Genitourinary Cancers Symposium
Patient perceptions of benefits and risks of adjuvant therapy in renal cell carcinoma.
First Author: Dena Battle
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase II study to evaluate anlotinib plus TQB2450 as adjuvant therapy in patients with esophageal squamous cell carcinoma (ALTER-E005).
First Author: Changying Guo